| |
| |
|
| Insider
Information: |
Mccourt Marion |
| Relationship: |
EVP Commercial |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
12,931 |
|
|
Indirect Shares
|
174 |
|
|
| Direct
Value |
$12,737,294 |
|
|
|
Indirect Value
|
$171,393 |
|
|
| Total
Shares |
13,105 |
|
|
| Total
Value |
$12,908,687 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
4
|
|
Stock
price went up :
|
0
|
4
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
4.0
|
| Percentage
Gain/Loss : |
0.0%
|
 31.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Medivation Inc |
MDVN |
Chief Operating Officer |
2016-09-28 |
0 |
2016-02-03 |
0 |
Premium* |
|
|
Regeneron Pharmaceuticals Inc |
REGN |
EVP Commercial |
2024-05-01 |
12,931 |
2024-05-01 |
174 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-12-12 |
4 |
D |
$856.71 |
$4,373,505 |
D/D |
(5,105) |
15,336 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-02-12 |
4 |
D |
$751.78 |
$959,271 |
D/D |
(1,276) |
20,803 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2024-02-05 |
4 |
S |
$934.71 |
$934,710 |
D/D |
(1,000) |
13,789 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-04-03 |
4 |
AS |
$818.80 |
$900,680 |
D/D |
(1,100) |
20,803 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-10-02 |
4 |
AS |
$827.00 |
$858,426 |
D/D |
(1,038) |
19,803 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-03-01 |
4 |
AS |
$759.89 |
$835,879 |
D/D |
(1,100) |
20,803 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2022-12-01 |
4 |
AS |
$756.19 |
$831,809 |
D/D |
(1,100) |
19,644 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-02-01 |
4 |
AS |
$752.19 |
$827,409 |
D/D |
(1,100) |
22,079 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2022-11-01 |
4 |
AS |
$750.00 |
$825,000 |
D/D |
(1,100) |
19,644 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-01-03 |
4 |
AS |
$721.86 |
$794,046 |
D/D |
(1,100) |
22,079 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-11-01 |
4 |
AS |
$783.91 |
$783,910 |
D/D |
(1,000) |
19,803 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2022-10-03 |
4 |
AS |
$705.39 |
$775,929 |
D/D |
(1,100) |
19,644 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-02-07 |
4 |
S |
$769.04 |
$769,040 |
D/D |
(1,000) |
22,079 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2022-06-01 |
4 |
AS |
$669.51 |
$736,461 |
D/D |
(1,100) |
19,644 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2022-11-04 |
4 |
S |
$727.82 |
$727,820 |
D/D |
(1,000) |
19,644 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2022-05-02 |
4 |
AS |
$656.97 |
$722,667 |
D/D |
(1,100) |
19,644 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2023-12-08 |
4 |
D |
$843.79 |
$718,909 |
D/D |
(852) |
18,951 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2022-04-01 |
4 |
AS |
$701.82 |
$701,820 |
D/D |
(1,000) |
19,644 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2021-09-01 |
4 |
AS |
$674.72 |
$674,720 |
D/D |
(1,000) |
17,038 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2022-07-01 |
4 |
AS |
$587.76 |
$646,536 |
D/D |
(1,100) |
19,644 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2021-11-01 |
4 |
AS |
$640.00 |
$640,000 |
D/D |
(1,000) |
17,038 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2022-08-01 |
4 |
AS |
$581.53 |
$639,683 |
D/D |
(1,100) |
19,644 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2022-09-01 |
4 |
AS |
$577.62 |
$635,382 |
D/D |
(1,100) |
19,644 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2022-01-03 |
4 |
AS |
$625.00 |
$625,000 |
D/D |
(1,000) |
19,644 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Commercial |
• – – |
2022-03-01 |
4 |
AS |
$615.39 |
$615,390 |
D/D |
(1,000) |
19,644 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
